AISurfingShort, clear updates with the original source one click away
← Back to brief
Companies Funding→Reported→The New York Times / AI

Chai Discovery Raises $400M at $3.8B Valuation for AI Drug Discovery

Jul 14, 2026

Chai Discovery, an AI drug discovery startup, has raised $400 million in funding, bringing its valuation to $3.8 billion. The investment reflects growing investor interest in leveraging artificial intelligence to accelerate drug development.

Why it matters: This funding round highlights the expanding influence of AI in pharmaceutical research and development.

Full story at: The New York Times / AI ↗

Related coverage

Enterprise AI faces a trust gap as agents produce confident wrong answers from unreliable contextThe AI compute gap: Enterprises are buying infrastructure faster than they can measure what it costsApplied Computing raises $20M to build AI foundation model for oil and gas plants